If you have been reading about thymosin beta-4 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-12-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Supplied as a lyophilised cake in sealed vials |
| Solubility class | Freely soluble in water | Polar and charged side chains dominate the sequence |
| Typical storage temperature | -20 °C or below | Dry and dark; a desiccant is often recommended |
| Identity confirmation | Mass spectrometry | Observed mass compared with the theoretical value |
| Common synonyms | Thymosin beta-4 fragment | Also written as T beta 4 fragment 17-23 |
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Criticism arose that a person with farming links should have been chosen, for the bikini-clad girls on the cover of Town magazine, which were considered risqué at the time, and for jokes in the magazine at the expense of the Royal Family. He was selected after a stirring speech to around 540 assembled members of the local Conservative Association on Friday 26 March 1965. Crick believes that this is a rare example in politics of a single speech determining a career. Only 27 members supported an amendment to refer the matter back to the selection committee and 14 opposed Heseltine's adoption altogether. Thereafter his name stopped appearing as "publisher" on his magazines. He had to learn about farming, an important issue in the seat, about which he knew almost nothing.
=== Release === Tau is involved in uptake and release processes, which are known as seeding. Uptake of tau protein requires the presence of heparan sulfate proteoglycans at the cell surface, which happens by macropinocytosis. On the other hand, tau release depends on neuronal activity. Many factors influence tau release such as, for example, the isoforms or MAPT mutations that change the extracellular level of tau. According to Asai and his colleagues, the spreading of tau protein occurs from the entorhinal cortex to the hippocampal region in the early stages of the disease. They also suggested that microglia were also involved in the transport process, and their actual role is still unknown.
Trump's previous comments suggesting he could "terminate" the Constitution to reverse his election loss, his claim that he would only be a dictator on "day one" of his presidency and not afterwards, his promise to use the Justice Department to go after his political enemies, his plan to use the Insurrection Act of 1807 to deploy the military for law enforcement in primarily Democratic cities and states, attempts to overturn the 2020 United States presidential election, his baseless predictions of voter fraud in the 2024 election, and his public embrace and celebration of the January 6 United States Capitol attack, raised concerns over the state of democracy in the United States. Trump's political operation said that it planned to deploy more than 100,000 attorneys and volunteers to polling places across battleground states, with an "election integrity hotline" for poll watchers and voters to report alleged voting irregularities.
=== EC 1.2.99: With unknown physiological acceptors === EC 1.2.99.1: Now EC 1.17.99.4, uracil/thymine dehydrogenase EC 1.2.99.2: Now EC 1.2.7.4, carbon-monoxide dehydrogenase (ferredoxin) EC 1.2.99.3: Now EC 1.2.5.2, aldehyde dehydrogenase (quinone) EC 1.2.99.4: Now EC 1.2.98.1, formaldehyde dismutase EC 1.2.99.5: Now EC 1.2.7.12, formylmethanofuran dehydrogenase EC 1.2.99.6: carboxylate reductase EC 1.2.99.7: aldehyde dehydrogenase (FAD-independent) EC 1.2.99.8: glyceraldehyde dehydrogenase (FAD-containing) EC 1.2.99.9: Now EC 1.17.98.3, formate dehydrogenase (coenzyme F420) EC 1.2.99.10: 4,4′-diapolycopenoate synthase
Colistimethate sodium may be used to treat Pseudomonas aeruginosa infections in patients with cystic fibrosis, and it has come into recent use for treating multidrug-resistant Acinetobacter infection, although resistant forms have been reported. Colistimethate sodium has also been given intrathecally and intraventricularly in Acinetobacter baumannii and Pseudomonas aeruginosa meningitis and ventriculitis Some studies have indicated that colistin may be useful for treating infections caused by carbapenem-resistant isolates of Acinetobacter baumannii. Colistin sulfate may be used to treat intestinal infections, or to suppress colonic flora. Colistin sulfate is also used in topical creams, powders, and otic solutions. Colistin A (polymyxin E1) and colistin B (polymyxin E2) can be purified individually to research and study their effects and potencies as separate compounds.
Sources: en.wikipedia.org
== Honours and awards == Doctorate honoris causa, Politics, Moscow State Institute of International Relations, Moscow, Russian Federation. Doctorate honoris causa, Duncan of Jordanstone College, University of Dundee, Scotland, United Kingdom. Ehrenbürgerschaft, Honorary Citizenship, awarded by the Christian Albrecht University, Kiel, Germany. Орден Дружбы, Order of Friendship presented by President Vladimir Putin of the Russian Federation. Нагрудный знак "Почетному полярнику", Honorary Polar Explorer Medal, Aspol, Moscow, Russian Federation. མངའ་བདག་དཔལ་གྱི་འཁོར་ལོ། Nga Dap Pel Gi Khorlo, The Order of the Druk Gyalpo, presented by King Jigme Khesar Namgyel Wangchuck of Bhutan. Silver Medal of Russian Geographic Society, awarded by the RGS, Russian Federation. Medal of Honour, granted by the Granada Dance and Music International Festival, Spain. Knight of the Order of St John by Queen Elizabeth II. The winner of the national award "Crystal Compass". (Russia)
immunohistochemistry (IHC) A branch of histochemistry which makes use of antibodies conjugated to some kind of molecular label in order to detect the presence or localization of complementary antigenic structures in tissue samples. See also immunostaining.
Army divisions, while the ARVN, in the invasion of Laos, had only assigned 2 divisions Under the cover of air strikes flown by the U.S. Air Force and the U.S. Navy, the ARVN advanced 20 miles into Laos and finally took the ruins of the town of Tchepone, which had been heavily bombed by the Americans, but were then pinned down by intense PAVN artillery fire from the hills above, making any further advance impossible. In March, Kissinger sent his deputy Haig to inspect the situation personally, leading him to report that the ARVN officers lacked courage and did not want to fight, making retreat the only option. The retreat, when it began, turned into a rout. Kissinger wrote that Lam Son had fallen "far short of our expectations", which he blamed on bad American planning, poor South Vietnamese tactics and Nixon's leadership style, leading Karnow to write that he blamed "everyone, characteristically, except himself". In late May 1971, Kissinger returned to Paris to fruitlessly meet again with Tho. The North Vietnamese demand that Thiệu step down proved to the main obstacle. Kissinger did not want a repeat of the prolonged bout of political instability that characterized South Vietnam from 1963 to 1967 and believed Thiệu was a force for order. Tho suggested to Kissinger that Americans "stop supporting" Thiệu who was running for reelection in a ballot scheduled for 3 October 1971.
== Relationship with autoimmune diseases and breast cancer == Microchimerism has been implicated in autoimmune diseases. Independent studies repeatedly suggested that microchimeric cells of fetal origin may be involved in the pathogenesis of systemic sclerosis. Moreover, microchimeric cells of maternal origin may be involved in the pathogenesis of a group of autoimmune diseases found in children, i.e. juvenile idiopathic inflammatory myopathies (one example would be juvenile dermatomyositis). Microchimerism has now been further implicated in other autoimmune diseases, including systemic lupus erythematosus. Contrarily, an alternative hypothesis on the role of microchimeric cells in lesions is that they may be facilitating tissue repair of the damaged organ. Moreover, fetal immune cells have also been frequently found in breast cancer stroma as compared to samples taken from healthy women. It is not clear, however, whether fetal cell lines promote the development of tumors or, contrarily, protect women from developing breast carcinoma.
== Overdose == In the event of an overdose of elagolix, the person should be monitored for any signs or symptoms of adverse reactions and should be treated on a symptomatic basis as needed. Elagolix has been assessed in clinical studies at a dose as high as a single administration of 1,200 mg, which resulted in concentrations of the medication that were 17 times higher than with the typical high clinical dosage of 200 mg twice per day. No adverse effects were mentioned. Chronic overdosage of elagolix may result in greater suppression of estradiol levels and a consequent increased risk of bone loss with long-term therapy.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.
It corresponds to the actin-binding region of thymosin beta-4. Commercial synthesis reproduces that seven-residue stretch, usually with an acetyl group on the N-terminus.
It is not authorised as a medicine in the United States or the European Union and is distributed as a research chemical. Labels consequently carry research-use-only statements rather than clinical indications.
TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.